Denali Therapeutics OverviewDenali Therapeutics Net Income
Profitability analysis for DNLI.
Quarterly Net Income
-$128.45M
↑ 3.4% YoY
As of Mar 2026
Annual Net Income (TTM)
-$508.02M
↓ 11.91% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...